This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

UK antitrust watchdog case-handling in spotlight from drug case fight

By Simon Zekaria ( February 13, 2026, 15:59 GMT | Comment) -- The UK competition regulator’s case-handling reputation has been put on the line by its bid to challenge a court setback in its long-running fight against Pfizer and Flynn Pharma over drug pricing. To prevail, it must convince appeal judges that it has learned the lessons of judicial reprimand over flaws to its approach, including over legal tests and economic methodology.When the UK competition regulator opened its recent bid (see here) to challenge a court setback in its long-running fight against Pfizer and Flynn Pharma over drug pricing, it knew what it was putting on the line: its case-handling reputation....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections